Discuss This Drug

terlipressin

CHEBI:CHEBI_135905

Chemical Information

Molecular Formula
C52H74N16O15S2
Molecular Mass
1227.376
Charge
0
SMILES
[H]NCC(NCC(NCC(N[C@H]1CSSC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC1=O)CC2=CC=C(O)C=C2)=O)CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)C(N4CCC[C@H]4C(N[C@@H](CCCCN)C(NCC(N)=O)=O)=O)=O)=O)=O)=O
InChI
InChI=1S/C52H74N16O15S2/c53-17-5-4-9-31(45(76)60-23-41(57)72)63-51(82)38-10-6-18-68(38)52(83)37-27-85-84-26-36(61-44(75)25-59-43(74)24-58-42(73)22-54)50(81)65-34(20-29-11-13-30(69)14-12-29)48(79)64-33(19-28-7-2-1-3-8-28)47(78)62-32(15-16-39(55)70)46(77)66-35(21-40(56)71)49(80)67-37/h1-3,7-8,11-14,31-38,69H,4-6,9-10,15-27,53-54H2,(H2,55,70)(H2,56,71)(H2,57,72)(H,58,73)(H,59,74)(H,60,76)(H,61,75)(H,62,78)(H,63,82)(H,64,79)(H,65,81)(H,66,77)(H,67,80)/t31-,32-,33-,34-,35-,36-,37-,38-/m0/s1
InChIKey
BENFXAYNYRLAIU-QSVFAHTRSA-N

Alternative Names

  • glycylpressin
  • glypressin
  • remestyp
  • Triglycyl-8-lysine-vasopressin

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:135905
DRON_00010000
57048
oboInOwl#hasDbXref
HMDB:HMDB0015569

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

core#notation
CHEBI:135905
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
57048
oboInOwl#hasDbXref
HMDB:HMDB0015569
oboInOwl#id
CHEBI:135905
rxcui
2612436
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
route
INTRAVENOUS
marketing_start_date
20220914
active_ingredient_strength
4 g/4g
labeler_name
Mallinckrodt Hospital Products Inc.
package_marketing_start_date
06-NOV-17
generic_name
TERLIPRESSIN
product_ndc
41701-009
spl_id
dde1debd-9de6-46c2-9dff-d606a0434f95
active_ingredient_name
TERLIPRESSIN
package_ndc
41701-009-08
package_description
1 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (41701-009-08) / 10 g in 1 BOTTLE, PLASTIC (41701-009-07)
brand_name
Terlivaz
brand_name_base
Terlivaz
application_number
NDA022231
manufacturer_name
Mallinckrodt Hospital Products Inc.
unii
7Z5X49W53P
spl_set_id
3a35b86c-f451-4fac-8499-43019e4da354
nui
N0000194046
pharm_class_epc
Vasopressin Receptor Agonist [EPC]
pharm_class
Vasopressin Receptor Agonists [MoA]
pharm_class_moa
Vasopressin Receptor Agonists [MoA]
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#2_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_11823
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_110305
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect4662
owl#annotatedSource
t108902
owl#someValuesFrom
t3906368